ODION, GEGE – Trademark Portfolio

Entity Type: 01

ODION, GEGE holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include OPTIWORLD and OPTI– WORLD COMMITED TO YOUR VISION CARE. The owner is based in SNELLVILLE, GA.

2851 CANDLER RD., DECATUR, GA 30034

SNELLVILLE, GA 30039

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

ODION, GEGE's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does ODION, GEGE have?

ODION, GEGE has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does ODION, GEGE file in?

ODION, GEGE files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are ODION, GEGE's most well-known trademarks?

ODION, GEGE's registered trademark portfolio includes well-known marks such as OPTIWORLD and OPTI– WORLD COMMITED TO YOUR VISION CARE. These are among 2 currently registered trademarks in the portfolio.

What is ODION, GEGE's trademark registration success rate?

ODION, GEGE has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.